News

ResMed, a San Diego-based company that develops solutions for sleep-disordered breathing and respiratory care, recently announced it will acquire Inova Labs, a medical device company in Austin, Texas, that develops and commercializes advanced oxygen therapies. Oxygen therapy is the administration of oxygen as a medical intervention, and it can be used…

The Aerobika device, from Trudell Medical International in Canada, is a drug-free, easy-to-use, and clinically supported product to help patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis cope with the disease symptoms — especially in the colder winter months. The device opens up the lungs and creates…

Qualcomm Incorporated recently announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global partnership to advance a next generation inhaler to treat chronic obstructive pulmonary disease (COPD). Under the terms of the collaboration, Qualcomm Life is developing the reference design for the small and disposable module to power the next generation Breezhaler™, part of Novartis’…

Researchers discovered that the CYLD protein turns off pathogen-induced inflammatory responses mediated by the myeloid differentiation factor 88 (MyD88), thereby preventing uncontrolled inflammation from damaging tissues and eventually inducing chronic obstructive pulmonary disease (COPD). The study, titled “Deubiquitinase CYLD acts as a negative regulator for bacterium NTHi-induced inflammation…

GCE Healthcare recently announced the launch of the Zen-O portable oxygen concentrator (POC), a device designed to help patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD), to better manage their oxygen therapy inside or outside the home. The device is the first product to be developed at  GCE’s new manufacturing…

Scientists have created a model of the human small airway using organ-on-a-chip technology that can help researchers study inflammatory lung diseases like chronic obstructive pulmonary disease (COPD) and asthma outside a patient’s body, and potentially makes it possible to more easily identify new biomarkers and evaluate drug candidates. The study, by researchers at the Harvard John A.

A new study revealed that corticosteroid treatment in patients with chronic obstructive pulmonary disease (COPD) or asthma increases their risk of developing a specific form of lung cancer – squamous cell carcinoma. The study, “The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous…

Inova Labs Inc., a company dedicated to medical devices for the treatment of respiratory conditions including chronic obstructive pulmonary disease (COPD), recently received the New Product Award 2015 for its oxygen concentrator system Activox DUO2™. The award was given by HME Business, part of the HME Media Group, which…

LifeMap Solutions recently announced that its free iOS app, COPD Navigator is now available for download on iTunes. An enhanced version branded as SuperCare iBreathe, deployed by SuperCare Health, will also soon be released. LifeMap, a digital-health arm of BioTime, Inc., developed the app in close…

A dossier assessment developed by the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of the fixed-dose combination therapy tiotropium plus olodaterol (Spiolto Respimat), approved this year for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. The study compared tiotropium/olodaterol…